Dermapharm Holding SE buy PapaSmurf
Summary
This prediction ended on 08.03.24 with a price of €37.54. With a performance of -4.14%, the BUY prediction for Dermapharm Holding SE by PapaSmurf closed slightly in the red. PapaSmurf has a follow-up prediction for Dermapharm Holding SE where he still thinks Dermapharm Holding SE is a Buy. PapaSmurf has 50% into this predictionDermapharm Holding is a Munich-based pharmaceutical company that develops innovative drug formulations and medical devices. It is listed on the Frankfurt Stock Exchange and has a strong presence in Germany and Europe. The company's product portfolio includes preparations for both prescription and over-the-counter drugs, as well as medical devices used in dermatology and urology. Dermapharm Holding differentiates itself from competitors by focusing on niche markets and developing new products in-house through its research and development activities.
Performance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Dermapharm Holding SE | -0.695% | -0.695% | -17.246% |
iShares Core DAX® | -0.116% | 1.953% | 14.155% |
iShares Nasdaq 100 | -2.733% | -1.273% | 31.828% |
iShares Nikkei 225® | -1.721% | 3.263% | 12.922% |
iShares S&P 500 | -1.527% | 0.194% | 27.117% |
Comments by PapaSmurf for this prediction
In the thread Trading Dermapharm Holding SE